The company expects full year 2025 global net ORLADEYO revenue will be between $515 million and $535 million. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on BCRX: BioCryst reports Q4 preliminary revenue $130.8M, consensus $128.65M BioCryst reports inducement grants under Nasdaq listing rule BioCryst price target raised to $18 from $16 at JMP Securities BioCryst launches Orladeyo in ireland
